Akeso Drops Most in 3 Months on Mixed Drug Data From US Partner

Akeso Inc.’s shares slumped after US partner Summit Therapeutics Inc. unveiled new data that cast doubt on the future of their closely-watched lung cancer drug in America....

Redirecting to full article...